Medicare & Medicaid
Medicare Part D beneficiaries can have higher out-of-pocket spending for generics if they use expensive specialty drugs.
More than half of facilities met the expected level of staffing less than 20% of the time during the one-year study period.
HEDIS data underreported hospital admissions for at least three medical conditions, and the excluded admissions had higher readmission rates.
Patients in Medicaid expansion states shifted their ED usage toward more critical injuries and illnesses.
New survey shows health executives are ready for increased risk assumption through commercial payers and Medicare.
At question is whether a temporary cap on funds makes retroactive payments moot, even as insurers upheld their part of the bargain under the Affordable Care Act.
Not only were there no employment changes, but Medicaid coverage rates have been dropping due to confusion and lack of awareness.
The expedited process and drug access would allow clinicians to complete the process online under new e-prescribing standards.
Rule misleads patients about their out-of-pocket costs for prescription drugs, a factor the manufacturers say HHS already concedes.
Hospitals said cuts to 340B savings would force them to scale back certain programs, though the 340B program remains controversial.